BRITISH AMERICAN TOBACCO (BATS.L)

Key Updates

British American Tobacco (BATS.L) has pulled back 2.10% to £4,576 since the June 29 report (£4,674), fully retracing the immediate post-restructuring reaction and consolidating below the prior recovery high. The retreat is directly attributable to the market's digestion of the June 29 workforce reduction announcement — a 9,000-role restructuring representing ~19% of the global headcount — alongside a downward revision to 2026 cigarette volume guidance issued earlier in June. YTD performance remains constructively positive at +8.59%, though the stock has surrendered meaningful ground from its recent peak.

Current Trend

The YTD trend remains positive (+8.59%), but price action since early June has been choppy and corrective. The sequence of moves — sharp decline from early June guidance cut, partial recovery to £4,674 by June 29, and now a renewed -2.10% leg lower — reflects a pattern of buy-the-restructuring followed by sell-the-news behaviour. Key observations:

• The stock is now -2.16% on the day and -2.18% over five days, indicating sustained near-term selling pressure rather than a one-day event.
• The 6-month return of +9.08% confirms the medium-term uptrend remains intact, providing a constructive backdrop despite short-term volatility.
• The £4,576 level sits between the June 19 trough of approximately £4,361 (support) and the June 29 recovery peak of £4,674 (resistance). A break below £4,450 would materially challenge the YTD recovery narrative.

Investment Thesis

The core thesis for BATS.L rests on three pillars: (1) structural cost reduction generating £600 million in annual savings by 2028 via the workforce and operational restructuring programme; (2) accelerating revenue diversification into smoke-free alternatives — vapes (Vuse) and nicotine pouches (Velo) — now guided to grow at mid-teen percentages in 2026; and (3) resilient combustible profitability providing cash generation to fund the transition. The June restructuring announcement, while creating short-term share price noise, materially reinforces pillar (1). The downward revision to cigarette volume guidance (now -2.5% vs. prior -2.0%) represents a modest headwind to pillar (3), partially offset by the upgrade to new-category revenue guidance (mid-teens from low double-digits).

Thesis Status

The investment thesis is intact but under moderate execution risk. The restructuring programme is now confirmed and underway, lending credibility to the £600 million savings target. However, steeper-than-expected cigarette volume declines in APAC/MEA and rising U.S. competitive pressure introduce uncertainty around the pace of combustible cash generation. The company has maintained its full-year guidance of 3%–5% revenue growth and 4%–6% adjusted profit from operations growth, which is a stabilising factor. The current price decline appears to reflect near-term uncertainty around restructuring execution and volume trends rather than a fundamental deterioration of the long-term thesis.

Key Drivers

The following developments are the primary drivers of current price action and the medium-term outlook:

• Major workforce restructuring (June 29): BAT confirmed the elimination of ~9,000 roles (5,500 direct cuts + 3,500 outsourced to Accenture), representing ~19% of its 47,000-person global workforce. The programme targets £600 million in annual cost savings by 2028 and includes factory network consolidation and supply-chain relocation. U.S. operations are excluded. Initial share price reaction was a 1.4%–3.2% decline. BBC | Bloomberg
• Downgraded cigarette volume guidance (June 2): BAT revised its 2026 global cigarette industry volume forecast to -2.5% (from -2.0%), citing slower-than-expected progress in APAC/MEA and heightened U.S. competitive pressure. The announcement triggered a 3.2%–3.7% single-day decline. Morningstar | WSJ
• Upgraded new-category revenue guidance (June 2): Simultaneously, BAT raised its 2026 new-category revenue growth forecast to mid-teens (from low double-digits), driven by Vuse vapes and Velo nicotine pouches. This partially offsets combustible headwinds and validates the smoke-free pivot. Bloomberg
• AI and digital transformation: The Accenture outsourcing partnership is framed as part of a broader shift toward AI-enabled, technology-driven operations, with CEO Tadeu Marroco positioning the restructuring as making the company "more agile, cost-disciplined, and technology-enabled." The Guardian
• Full-year guidance maintained: Despite the mixed guidance revisions, BAT has held its full-year 2026 targets of 3%–5% revenue growth and 4%–6% adjusted profit from operations growth, providing a floor for investor expectations. Morningstar

Technical Analysis

BATS.L is trading at £4,576, in a short-term corrective phase after failing to sustain the June 29 recovery high of approximately £4,674. Key technical observations:

• Resistance: £4,674 (June 29 recovery high) — the immediate ceiling. A reclaim of this level would re-establish bullish momentum.
• Support: £4,450–£4,361 zone — the June 17–19 trough cluster. This remains the critical support band; a close below £4,361 would constitute a lower low and negate the YTD recovery structure.
• Current positioning: At £4,576, the stock sits in the middle of the £4,361–£4,674 range, with no clear directional bias on a short-term basis.
• Momentum: The -2.16% daily and -2.18% five-day moves suggest persistent selling pressure, not a one-day anomaly. The 1-month return of -0.11% confirms the stock has been range-bound over the past four weeks.
• Medium-term structure: The 6-month gain of +9.08% and YTD gain of +8.59% confirm the broader uptrend remains intact. The current pullback is a second-order correction within a constructive medium-term trend.

Bull Case

• 1. £600 million structural cost savings programme underway: The confirmed restructuring of ~9,000 roles, with completion targeted by year-end, is projected to deliver £600 million in annual savings by 2028. This represents a material and quantified improvement to the cost structure, directly enhancing long-term earnings quality. The programme is already underway, reducing execution uncertainty. Bloomberg | Financial Times
• 2. New-category revenue growth upgraded to mid-teens: BAT raised its 2026 guidance for vapes and nicotine pouches to mid-teen percentage growth (from low double-digits), demonstrating accelerating momentum in the smoke-free portfolio. Vuse and Velo are growing at a rate that increasingly offsets combustible volume declines. Bloomberg | The Guardian
• 3. Full-year financial guidance maintained: Despite headwinds in cigarette volumes, BAT has maintained its 2026 full-year targets of 3%–5% revenue growth and 4%–6% adjusted profit from operations growth. This signals management confidence in the overall financial trajectory and limits downside risk to consensus estimates. Morningstar
• 4. AI and technology-enabled operational transformation: The Accenture partnership and broader AI integration strategy position BAT to structurally reduce its operating cost base beyond the immediate headcount reduction, potentially creating a more scalable and efficient business model for the smoke-free era. The Guardian | BBC
• 5. Resilient combustible revenue and profit momentum: Despite volume declines, BAT noted continued revenue and profit momentum in combustible products, indicating pricing power is partially compensating for volume erosion. U.S. operations under Reynolds American are unaffected by the restructuring, preserving the most profitable geography. Morningstar | WSJ

Bear Case

• 1. Steeper-than-expected cigarette volume decline accelerating: BAT downgraded its 2026 global cigarette industry volume forecast to -2.5% (from -2.0%), with the shortfall driven by underperformance in APAC/MEA and rising U.S. competitive pressure. The trend suggests the pace of combustible deterioration is outpacing prior management assumptions, compressing the cash generation runway that funds the smoke-free transition. Morningstar | WSJ
• 2. Restructuring execution risk on a significant scale: Eliminating or outsourcing ~19% of the global workforce by year-end is an operationally complex undertaking. Risks include disruption to manufacturing and supply-chain operations, potential loss of institutional knowledge, and execution delays that could defer the £600 million savings realisation beyond 2028. Financial Times | Bloomberg
• 3. Near-term restructuring costs and cash flow impact: Large-scale restructuring programmes of this nature typically involve material one-off charges (severance, outsourcing transition costs, factory consolidation) that will weigh on reported earnings and free cash flow in the near term before savings are realised. The provided data does not quantify these charges, representing a source of earnings uncertainty. BBC | WSJ
• 4. Competitive pressure intensifying in U.S. market: BAT specifically cited increased competitive pressure in the U.S. as a driver of the cigarette volume guidance downgrade. The U.S. is BAT's most profitable market (Reynolds American is excluded from the restructuring), making any sustained competitive deterioration there a disproportionate risk to group profitability. Morningstar
• 5. Market scepticism reflected in repeated negative price reactions: BAT shares have declined on multiple material announcements — 3.2%–3.7% on the June 2 guidance revision and 1.4% on the June 29 restructuring news. The current -2.10% move since the last report continues this pattern, suggesting the market is not fully crediting management's transformation narrative and that investor confidence in execution remains limited. WSJ | The Guardian